Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Anixa Biosciences Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 45 | 49 | +4 |
| Shares | 3.65M | 3.93M | +280.9K (+7.7%) |
| Value | $11.7M | $12.8M | +$1.17M (+10.0%) |
New holders (7)
Institutions that held Anixa Biosciences Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mission Wealth Management, LP | 501,168 | $1.64M | 0.06% |
| Dakota Wealth Management | 15,000 | $49.0K | 0.00% |
| Squarepoint Ops LLC | 13,514 | $44.2K | 0.00% |
| The PNC Financial Services Group, Inc. | 3,039 | $9.94K | 0.00% |
| Simplex Trading, LLC | 1,014 | $3.00K | 0.00% |
| Park Circle Co | 500 | $1.64K | 0.00% |
| Qube Research & Technologies Ltd | 4 | $13 | 0.00% |
Sold out (3)
Institutions that held Anixa Biosciences Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Stifel Financial Corp | 50,000 | $160.0K |
| Segall Bryant & Hamill, LLC | 17,400 | $55.7K |
| Commonwealth Equity Services, LLC | 10,571 | $34.0K |